139 related articles for article (PubMed ID: 1835095)
21. Morphological alterations and DNase deficiency in phenobarbital promotion of N-nitrosomorpholine initiated rat hepatocarcinogenesis.
Taper HS; Lans M; de Gerlache J; Fort L; Roberfroid M
Carcinogenesis; 1983; 4(2):231-4. PubMed ID: 6825212
[TBL] [Abstract][Full Text] [Related]
22. [Early histochemical markers of hepatocarcinogenesis].
Vinarchuk MP; Bykorez AI
Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
[TBL] [Abstract][Full Text] [Related]
23. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.
Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R
Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596
[TBL] [Abstract][Full Text] [Related]
24. Ornithine decarboxylase induction and DNA damage as a predictive assay for potential carcinogenicity.
Kitchin KT; Brown JL; Kulkarni AP
Prog Clin Biol Res; 1991; 369():137-44. PubMed ID: 1946513
[No Abstract] [Full Text] [Related]
25. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
[No Abstract] [Full Text] [Related]
26. Initiation-promotion-initiation. Induction of neoplastic foci within islands of precancerous liver cells in the rat.
Scherer E; Feringa AW; Emmelot P
IARC Sci Publ; 1984; (56):57-66. PubMed ID: 6536610
[TBL] [Abstract][Full Text] [Related]
27. [Fructosephosphate aldolase during experimental liver damage in rats. II. Liver damage by diethylnitrosamine].
Dikow AL; Hadjiolov DC
Z Klin Chem Klin Biochem; 1970 Sep; 7(5):556-8. PubMed ID: 5505969
[No Abstract] [Full Text] [Related]
28. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
Waddell WJ; Fukushima S; Williams GM
Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
[TBL] [Abstract][Full Text] [Related]
29. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
[TBL] [Abstract][Full Text] [Related]
30. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
Kitagawa T; Sugano H
Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
[No Abstract] [Full Text] [Related]
31. N-Nitrosodiphenylamine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():213-25. PubMed ID: 7049904
[No Abstract] [Full Text] [Related]
32. Carcinogenicity of diallylnitrosamine following intragastric administration to Syrian hamsters.
Grandjean CJ; Althoff J; Pour PM
J Natl Cancer Inst; 1985 May; 74(5):1043-6. PubMed ID: 3858573
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat.
Scherer E; Emmelot P
Eur J Cancer (1965); 1975 Oct; 11(10):689-96. PubMed ID: 173556
[No Abstract] [Full Text] [Related]
34. [Stimulation, by acute inflammation, of the proliferation in preneoplastic hepatocyte foci expressing the gamma glutamyl transpeptidase, induced by diethylnitrosamine in adult rats].
Nadal C; Valéro D; Périn F
C R Acad Sci III; 1988; 307(5):239-44. PubMed ID: 2903788
[TBL] [Abstract][Full Text] [Related]
35. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
[TBL] [Abstract][Full Text] [Related]
36. Newer insights into the pathogenesis of liver cancer.
Farber E; Solt D; Cameron R; Laishes B; Ogawa K; Medline A
Am J Pathol; 1977 Nov; 89(2):477-82. PubMed ID: 920780
[TBL] [Abstract][Full Text] [Related]
37. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation.
Jirtle RL; Meyer SA; Brockenbrough JS
Prog Clin Biol Res; 1991; 369():209-16. PubMed ID: 1946518
[No Abstract] [Full Text] [Related]
38. Immunocytochemical demonstration of a phenobarbital-inducible cytochrome P450 in putative preneoplastic foci of rat liver.
Schulte-Hermann R; Roome N; Timmermann-Trosiener I; Schuppler J
Carcinogenesis; 1984 Feb; 5(2):149-53. PubMed ID: 6697432
[TBL] [Abstract][Full Text] [Related]
39. Persistent proliferation of normal hepatocytes and promotion of preneoplastic development by N-nitrosodibenzylamine in rats.
Blaszyk H; Hartmann A; Danz M
J Cancer Res Clin Oncol; 1993; 120(1-2):71-5. PubMed ID: 8270612
[TBL] [Abstract][Full Text] [Related]
40. Proliferation of rat liver cells in preneoplastic nodules after stimulation of liver growth by xenobiotic inducers.
Ohde G; Schuppler J; Schulte-Hermann R; Keiger H
Arch Toxicol Suppl; 1979; (2):451-5. PubMed ID: 88929
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
